The role of hypoglycemia in the development of cardiovascular catastrophes (experience of clinical studies)
- Authors: Doskina E.V1, Almazova I.I1, Tanhilevich B.M2
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
- City Clinical Hospital S.P.Botkin of the Department of Health of Moscow
- Issue: Vol 9, No 3 (2018)
- Pages: 47-53
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45962
- DOI: https://doi.org/10.26442/2221-7185_2018.3.47-53
- ID: 45962
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
E. V Doskina
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: Evd-evd2008@yandex.ru
канд. мед. наук, доц. каф. эндокринологии 125995, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
I. I Almazova
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federationканд. мед. наук, ассистент каф. терапии и подростковой медицины 125995, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
B. M Tanhilevich
City Clinical Hospital S.P.Botkin of the Department of Health of Moscowканд. мед. наук, врач анестезиолог-реаниматолог, зав. 61-м отд-нием 125284, Russian Federation, Moscow, 2-y Botkinskiy pr-d, d. 5
References
- Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным сахарным диабетом» Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 8-й вып. 2017 г.
- Cariou B, Fontaine P, Eschwege E. Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 dabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabet Metab 2015; 41 (2): 116-25.
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
- Reichard P, Berglund B, Britz A. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991; 230: 101-8.
- MacLeod K.M, Hepburn D.A, Frier B.M. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993; 10: 238-45.
- Khunti K, Alsifri S, Aronson R. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabet Obes Metab 2016; 18 (9): 907-15.
- Herman W.H, Ilag L.L, Johnson S.L et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with Type 2 Diabetes. Diabetes Care 2005; 28: 1568-73.
- Hurst R.T, Lee R.W. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 2003; 139: 824-34.
- Kip K.E, Faxon D.P, Detre K.M et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-25.
- Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.
- Stamler J, Vaccaro O, Neaton J.D et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
- Alderman E.L, Corley S.D, Fisher L.D et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol 1993; 22: 1141-54.
- Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol 1995; 75: 894-903.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53.
- The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375 (9733): 2215-22.
- http: //www.athero.ru/UKPDS-intens-standard.pdf
- Акчурин Р.С., Власова Э.Е., Мершин К.В. Сахарный диабет и хирургическое лечение ишемической болезни сердца. Вестн. РАМН. 2012; 1: 14-9. / Akchurin R.S., Vlasova E.E., Mershin K.V. Saharnyj diabet i hirurgicheskoe lechenie ishemicheskoj bolezni serdca. Vestn. RAMN. 2012; 1: 14-9. [in Russian]
- Soinio M, Marniemi J, Laakso M et al. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. A 7-year follow-up study. Diabetes Care 2006;29 (2): 329-33.
- Nathan David M et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions. Diabetes 2013; 62 (12): 3976-86.
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. N Engl J Med 2005; 353: 2643-53.
- Writing Group for the DCCT/EDIC Research Group. Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality. JAMA 2015; 313 (1): 45-53.
- Cleary P.A, Orchard T.J, Genuth S et al. The effect of intensive glycemic treatment on Coronary Artery Calcification on Type 1 Diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 2006; 55.
- Farhmann E.R, Adkins L, Loader J et al. Severe hypoglycemia and coronary artery calcification during the diabetes control and complcations trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes Res Clin Pract 2015; 107 (2): 280-9.
- UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance. Diabetologia 1991; 34 (12): 877-90.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352 (9131): 837-53.
- Holman R.R, Paul S.K, Bethel M.A et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359 (15): 1577-89.
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008; 358: 2545-59.
- Bonds D.E, Miller M.E, Bergenstal R.M et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010; 340: b4909.
- Riddle M.C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010; 122 (8): 844-6.
- Patel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358 (24): 2560-72.
- Duckworth W, Abraira C, Moritz T VADT Investigators et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009; 360: 129-39.
- Saremi A, Bahn G.D, Reaven P.D. A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care 2016; pii: dc152107.
- Hayward R.A, Reaven P.D, Emanuele N.V. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2015; 373 (10): 978.
- Gerstein H.C, Bosch J, Dagenais G.R et al. ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012; 367 (4): 319-28.
- Mellbin L.G, Rydén L, Riddle M.C et al. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 2013; 34 (40): 3137-44.
- Bedenis R, Price A.H, Robertson C.M et al. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. A large clinical trial with some markers of inflammation that may serve as a starting-point for future trials. Diabetes Care 2014; 37 (12): 3301-8.
- Gota A, Arah O.A, Goto M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533. doi: 10.1136/bmj.f4533
- Gota A, Arah O.A, Goto M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533. doi: 10.1136/bmj.f4533
- Глюкометр Контур Плюс. http: //diabetes.ascensia.com.ru/ homepage/ / Gliukometr Kontur Plius. http: //diabetes. ascensia.com.ru/homepage/ [in Russian]
- Baum et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. Diab Tech Ther 2006; 8 (3): 347-57.